In individuals with obesity and cardiometabolic disorders, low irisin levels might be considered proarrhythmia markers, as obesity disrupts the balance in the adipose tissue and the endocrine function of the muscle tissue. The gene discussed is FNDC5; the disease is obesity disorder.